Interpace Diagnostics Group's total assets for Q1 2025 were $14.49M, a decrease of -2.01% from the previous quarter. IDXG total liabilities were $15.08M for the fiscal quarter, a -11.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.